In patients with poor prognosis pancreatic adenocarcinoma, W. Yao et al. analyzed the relationship between COL12A1 and cytoplasmic poly (A) binding protein-1 (PABPC1), a class of RNA-binding proteins known to modulate tumor progression. The gene discussed is COL12A1; the disease is pancreatic adenocarcinoma.